Assignee
ZOGENIX INTERNATIONAL LTD
GB·21 granted patents·34 pending applications·166 citations·filing 2015–2024
Top patents by PatentIndex Score
55 records- 0198US11634377B2Fenfluramine compositions and methods of preparing the sameZOGENIX INTERNATIONAL LTD·Filed 2021·Granted Apr 25, 2023·5 cites·16 claims
- 0298US11325882B2Metabolism resistant fenfluramine analogs and methods of using the sameZOGENIX INTERNATIONAL LTD·Filed 2020·Granted May 10, 2022·4 cites·3 claims
- 0398US11040018B2Formulation for inhibiting formation of 5-HT2B agonists and methods of using sameZOGENIX INTERNATIONAL LTD·Filed 2020·Granted Jun 22, 2021·10 cites·9 claims
- 0497US11673852B2Metabolism resistant fenfluramine analogs and methods of using the sameZOGENIX INTERNATIONAL LTD·Filed 2022·Granted Jun 13, 2023·2 cites·4 claims
- 0597US11406606B2Formulation for inhibiting formation of 5-HT2B agonists and methods of using sameZOGENIX INTERNATIONAL LTD·Filed 2022·Granted Aug 9, 2022·5 cites·22 claims
- 0696US11759440B2Formulation for inhibiting formation of 5-HT2B agonists and methods of using sameZOGENIX INTERNATIONAL LTD·Filed 2021·Granted Sep 19, 2023·3 cites·10 claims
- 0796US11612574B2Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ZOGENIX INTERNATIONAL LTD·Filed 2021·Granted Mar 28, 2023·4 cites·20 claims
- 0895US10351510B2Fenfluramine compositions and methods of preparing the sameZOGENIX INTERNATIONAL LTD·Filed 2018·Granted Jul 16, 2019·16 cites·18 claims
- 0995US10351509B2Fenfluramine compositions and methods of preparing the sameZOGENIX INTERNATIONAL LTD·Filed 2016·Granted Jul 16, 2019·16 cites·22 claims
- 1094US11786487B2Formulation for inhibiting formation of 5-HT2B agonists and methods of using sameZOGENIX INTERNATIONAL LTD·Filed 2021·Granted Oct 17, 2023·2 cites·9 claims
- 1194US11458111B2Ketogenic diet compatible fenfluramine formulationZOGENIX INTERNATIONAL LTD·Filed 2020·Granted Oct 4, 2022·5 cites·26 claims
- 1294US10689324B2Metabolism resistant fenfluramine analogs and methods of using the sameZOGENIX INTERNATIONAL LTD·Filed 2016·Granted Jun 23, 2020·11 cites·3 claims
- 1394US10603290B2Formulation for inhibiting formation of 5-HT2B agonists and methods of using sameZOGENIX INTERNATIONAL LTD·Filed 2018·Granted Mar 31, 2020·10 cites·10 claims
- 1493US10947183B2Fenfluramine compositions and methods of preparing the sameZOGENIX INTERNATIONAL LTD·Filed 2019·Granted Mar 16, 2021·10 cites·33 claims
- 1590US11571397B2Compositions and methods for treating seizure-induced sudden deathZOGENIX INTERNATIONAL LTD·Filed 2018·Granted Feb 7, 2023·6 cites·21 claims
- 1690US10950331B2Control system for control of distribution of medicationZOGENIX INTERNATIONAL LTD·Filed 2018·Granted Mar 16, 2021·11 cites·10 claims
- 1790US10682317B2Ketogenic diet compatible fenfluramine formulationZOGENIX INTERNATIONAL LTD·Filed 2018·Granted Jun 16, 2020·10 cites·11 claims
- 1890US10452815B2Control system for control of distribution of medicationZOGENIX INTERNATIONAL LTD·Filed 2015·Granted Oct 22, 2019·13 cites·9 claims
- 1989US10952976B2Compositions and methods for treating respiratory depression with fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2019·Granted Mar 23, 2021·11 cites·13 claims
- 2089US10517841B1Compositions and methods for treating respiratory depression with fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2019·Granted Dec 31, 2019·12 cites·22 claims
- 2184US2024245631A1Methods of treating lennox-gastaut syndrome using fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2024·Application pending·0 cites
- 2284US2024238222A1Methods of treating lennox-gastaut syndrome using fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2024·Application pending·0 cites
- 2376US2022370381A1Compositions and methods for treating seizure disordersZOGENIX INTERNATIONAL LTD·Filed 2022·Application pending·0 cites
- 2475US2023076320A1Norfenfluramine to treat dravet syndromeZOGENIX INTERNATIONAL LTD·Filed 2022·Application pending·0 cites
- 2573US2019091174A1Method of reducing seizure type experienced by a dravet patientZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
- 2671US2019091176A1Method of treating selected patient population experiencing dravet syndromeZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
- 2771US2020276136A1Method of treating selected patient population experiencing dravet syndromeZOGENIX INTERNATIONAL LTD·Filed 2020·Application pending·0 cites
- 2870US2023093150A1Changing cognitive function with fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2022·Application pending·0 cites
- 2968US2024299317A1Fenfluramine for Treatment of Conditions Associated with Spreading DepolarizationZOGENIX INTERNATIONAL LTD·Filed 2024·Application pending·0 cites
- 3068US2025032431A1Methods of treating rett syndrome using fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2024·Application pending·0 cites
- 3167US2019091173A1Method of increasing time between convulsive seizuresZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
- 3267US2020297665A1Compositions and methods for treating seizure disordersZOGENIX INTERNATIONAL LTD·Filed 2020·Application pending·0 cites
- 3367US2019125697A1Method of reduction in convulsive seizure frequencyZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
- 3467US2020253895A1Methods of treating lennox-gastaut syndrome using fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2020·Application pending·0 cites
- 3566US2022226262A1Methods of treating doose syndrome using fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2022·Application pending·0 cites
- 3666US2023165810A1Fenfluramine for treatment of conditions associated with spreading depolarizationZOGENIX INTERNATIONAL LTD·Filed 2022·Application pending·0 cites
- 3766US2018092864A1Compositions and methods for treating seizure disordersZOGENIX INTERNATIONAL LTD·Filed 2017·Application pending·0 cites
- 3866US2021158920A1Control system for control of distribution of medicationZOGENIX INTERNATIONAL LTD·Filed 2021·Application pending·0 cites
- 3965US2019091177A1Method of treating selected patient population experiencing dravet syndromeZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
- 4064US2019091175A1Method of reduction medication in treating dravet syndromeZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
- 4163US12144787B2Method of treating patients with a mutation in cyclin-dependent kinase-like 5 (CDKL5)ZOGENIX INTERNATIONAL LTD·Filed 2019·Granted Nov 19, 2024·0 cites·17 claims
- 4263US2018055789A1Formulation for inhibiting formation of 5-ht2b agonists and methods of using sameZOGENIX INTERNATIONAL LTD·Filed 2017·Application pending·0 cites
- 4360US2020170965A1Methods of treating doose syndrome using fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
- 4457US2020306210A1Changing cognitive function with fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2019·Application pending·0 cites
- 4554US2019091179A1Congnitive function with fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
- 4654US2018325909A1Combination treatment of specific forms of epilepsyZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
- 4754US2022193082A1Combination treatment of specific forms of epilepsyZOGENIX INTERNATIONAL LTD·Filed 2022·Application pending·0 cites
- 4853US2021113495A1Method of treating epilepsy or epileptic encephalopathy with fenfluramine in patients without pulmonary hypertensionZOGENIX INTERNATIONAL LTD·Filed 2019·Application pending·0 cites
- 4952US2021401776A1Method of treating refractory epilepsy syndromes using fenfluramine enantiomersZOGENIX INTERNATIONAL LTD·Filed 2019·Application pending·0 cites
- 5051US2019083425A1Formulation for inhibiting formation of 5-ht2b agonists and methods of using sameZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →